Natasha Leann Workman, CRNP Registered Nurse Medicare: Medicare Enrolled Practice Location: 339 Walker Chapel Plz Ste 115, Fultondale, AL 35068 Phone: 205-250-6424 |
Charles Ridgeway Payne, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 3631 Grand Central Ave, Fultondale, AL 35068 Phone: 205-535-6011 |
Mr. Blake Alan Hand, CRNP Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 3477 Lowery Pkwy Ste 137, Fultondale, AL 35068 Phone: 205-379-6040 Fax: 205-379-6039 |
Ms. Ladonya C. Pierce, RN Registered Nurse - Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 521 Park Ln, Fultondale, AL 35068 Phone: 205-808-9203 |
Jordan Faith Brantley, CRNP Registered Nurse Medicare: Medicare Enrolled Practice Location: 1311 Decatur Hwy, Fultondale, AL 35068 Phone: 205-379-6040 |
Catherine Labreche, DNP, CRNA Registered Nurse - Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 2001 Hickory Ln, Fultondale, AL 35068 Phone: 901-596-8393 |
News Archive
Results from a new media study among 600 physicians revealed that the majority (78%) reported that they do not agree with the new guidelines released by the Preventive Services Task Force of the Department of Health and Human Services recommending against regular mammography tests for women under 50 years old.
ProAssurance Corporation today highlighted recent rating actions by A.M. Best, affirming the "A" Excellent ratings assigned to the ProAssurance Group and upgrading The PICA Group and The Podiatry Insurance Company of America (PICA) to "A" (Excellent) and ProAssurance National Casualty to "A-" (Excellent). The ratings outlook for each is Stable. Further, Best affirmed the "A-" (Excellent) Ratings of ProAssurance Wisconsin and PACO Assurance Company, a subsidiary of PICA.
PolyMedix, Inc., an emerging biotechnology company focused on developing new therapeutic drugs to treat infectious diseases and acute cardiovascular disorders, has initiated a Phase 2 clinical trial, following conclusion of a review by the United States Food and Drug Administration (FDA) of a protocol submitted by PolyMedix, to assess the safety and efficacy of its heptagonist, PMX-60056, in reversing heparin in patients undergoing Percutaneous Coronary Intervention (PCI) procedures.
GE announced today it has completed the acquisition of API Healthcare, a healthcare workforce management solutions provider, headquartered in Hartford, WI.
› Verified 5 days ago